Botwood Nicholas A.J. (CIK 2066784) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-12). Recent activity: Buy SNDX (22,515 shares), Sell SNDX (34,280 shares), Buy SNDX (31,235 shares), Sell SNDX (31,235 shares), Buy SNDX (24,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-12 | Syndax Pharmaceuticals Inc (SNDX) | Head of R&D, CMO | Buy | 22,515 | $311,157 |
| 2026-06-12 | Syndax Pharmaceuticals Inc (SNDX) | Head of R&D, CMO | Sell | 34,280 | $617,040 |
| 2026-06-12 | Syndax Pharmaceuticals Inc (SNDX) | Head of R&D, CMO | Buy | 31,235 | $431,668 |
| 2026-06-12 | Syndax Pharmaceuticals Inc (SNDX) | Head of R&D, CMO | Sell | 31,235 | $566,603 |
| 2026-02-06 | Syndax Pharmaceuticals Inc (SNDX) | Head of R&D, CMO | Buy | 24,000 | $0 |
| 2026-02-06 | Syndax Pharmaceuticals Inc (SNDX) | Head of R&D, CMO | Buy | 36,000 | $0 |
| 2025-05-19 | Syndax Pharmaceuticals Inc (SNDX) | Head of R&D, CMO | Buy | 11,765 | $105,885 |
Source: SEC Form 4 filings · as of 2026-06-12